TokenPost topic

SPRO

1 TokenPost story is tagged SPRO. The newest appear first.

Latest SPRO stories

• Spero Therapeutics Posts $0.76 Q3 Loss Per Share, Cash Runway Into 2029

  The company had $107.9 million in cash and equivalents on Sept. 30, 2026, and expects the funds to support operations into the second half of 2029.

  Nov 12, 2026, 6:15 PM EST · Business